Thus, in this study, we sought to determine the methylation level of PPARGC1A in peripheral blood and whether the epigenetic modification of PPARGC1A could account for its diminished expression in the peripheral blood of patients with PD. Here, PPARGC1A is linked to Parkinson disease.